Dysport® Adult Lower Limb Spasticity Follow-on Study
Public ClinicalTrials.gov record NCT01251367. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase III, Prospective, Multicentre, Open Label, Extension Study, to Assess the Long Term Safety and Efficacy of Repeated Treatment of Dysport® Intramuscular Injection in the Treatment of Lower Limb Spasticity in Adult Subjects With Spastic Hemiparesis Due to Stroke or Traumatic Brain Injury
Study identification
- NCT ID
- NCT01251367
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Ipsen
- Industry
- Enrollment
- 352 participants
Conditions and interventions
Interventions
- Botulinum toxin type A Biological
Biological
Eligibility (public fields only)
- Age range
- 18 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 31, 2011
- Primary completion
- Mar 31, 2015
- Completion
- Mar 31, 2015
- Last update posted
- Sep 27, 2022
2011 – 2015
United States locations
- U.S. sites
- 15
- U.S. states
- 10
- U.S. cities
- 15
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Mayo Clinic Arizona | Scottsdale | Arizona | 85259 | — |
| Rancho Los Amigos | Downey | California | 90242 | — |
| Pacific Neuroscience Medical Group | Oxnard | California | 93030 | — |
| Associated Neurologist of Southern CT, PC | Fairfield | Connecticut | 06824 | — |
| Design Neuroscience Center | Miami | Florida | 33136 | — |
| Weill Cornell Medical College | New York | New York | 10065 | — |
| Island Neurological Associates | Plainview | New York | 11803 | — |
| University of North Carolina - Chapel Hill | Chapel Hill | North Carolina | 27599-7200 | — |
| Wake Forest University Baptist Medical Center | Winston-Salem | North Carolina | 27157 | — |
| Moss Rehab & Albert Einstein | Elkins Park | Pennsylvania | 19027 | — |
| Vanderbilt University | Nashville | Tennessee | 37232 | — |
| The University of Texas Southwestern Medical Center at Dalla | Dallas | Texas | 75390-9016 | — |
| University of North Texas HSC at Ben Hogan Center | Fort Worth | Texas | 76104 | — |
| University of Texas - Houston | Houston | Texas | 77030 | — |
| University of Utah School of Medicine | Salt Lake City | Utah | 84132 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 35 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01251367, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 27, 2022 · Synced May 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01251367 live on ClinicalTrials.gov.